Clinical Trial Update: Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating an add-on therapy consisting of sitagliptin, metformin, and a PPAR-gamma agonist for Type 2 Diabetes Mellitus has completed, with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Januvia (sitagliptin)
• PIOGLITAZONE (Pioglitazone)
• metformin (metformin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2009-07-03